Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31.8M Buy
422,311
+11,516
+3% +$821K 0.05% 305
2025
Q4
$25.4M Buy
410,795
+21,780
+6% +$1.28M 0.04% 345
2025
Q3
$22.8M Buy
389,015
+22,169
+6% +$1.29M 0.04% 345
2025
Q2
$21.4M Buy
366,846
+23,691
+7% +$1.34M 0.04% 349
2025
Q1
$17M Buy
343,155
+43,841
+15% +$2.24M 0.04% 374
2024
Q4
$13.4M Sell
299,314
-242,680
-45% -$11.5M 0.03% 389
2024
Q3
$26.1M Buy
541,994
+12,722
+2% +$613K 0.07% 304
2024
Q2
$26.9M Buy
529,272
+98,802
+23% +$5.41M 0.07% 296
2024
Q1
$23.4M Buy
430,470
+88,526
+26% +$4.61M 0.08% 300
2023
Q4
$19.3M Buy
341,944
+6,258
+2% +$354K 0.07% 332
2023
Q3
$20.8M Buy
335,686
+14,080
+4% +$891K 0.09% 296
2023
Q2
$19M Buy
321,606
+190,301
+145% +$12.1M 0.08% 320
2023
Q1
$9.69M Buy
131,305
+45,242
+53% +$3.49M 0.04% 462
2022
Q4
$6.29M Buy
86,063
+6,437
+8% +$509K 0.03% 540
2022
Q3
$6.67M Buy
79,626
+1,580
+2% +$136K 0.04% 517
2022
Q2
$6.22M Sell
78,046
-29,260
-27% -$2.84M 0.03% 534
2022
Q1
$11.1M Sell
107,306
-64,578
-38% -$5.35M 0.06% 404
2021
Q4
$12.9M Sell
171,884
-2,778
-2% -$194K 0.05% 336
2021
Q3
$11.3M Sell
174,662
-9,377
-5% -$573K 0.05% 362
2021
Q2
$11.2M Sell
184,039
-5,950
-3% -$352K 0.05% 363
2021
Q1
$10.2M Buy
189,989
+600
+0.3% +$32.6K 0.05% 337
2020
Q4
$9.1M Buy
189,389
+5,464
+3% +$242K 0.05% 344
2020
Q3
$7.18M Sell
183,925
-5,891
-3% -$214K 0.04% 366
2020
Q2
$6.07M Sell
189,816
-10,372
-5% -$361K 0.04% 387
2020
Q1
$6.79M Sell
200,188
-1,224
-0.6% -$49K 0.05% 335
2019
Q4
$9.62M Sell
201,412
-1,498
-0.7% -$72.4K 0.06% 284
2019
Q3
$10.1M Sell
202,910
-14,270
-7% -$728K 0.07% 256
2019
Q2
$11.6M Sell
217,180
-253,473
-54% -$13.2M 0.08% 242
2019
Q1
$24.8M Sell
470,653
-17,070
-3% -$889K 0.17% 132
2018
Q4
$22.9M Buy
487,723
+186,414
+62% +$9.72M 0.17% 131
2018
Q3
$17.3M Sell
301,309
-21,420
-7% -$1.19M 0.09% 222
2018
Q2
$17.5M Sell
322,729
-5,723
-2% -$284K 0.1% 207
2018
Q1
$15.5M Buy
+328,452
New +$16.5M 0.09% 225

Other funds holding NTR

Aviva's NTR Position: Q1 2026 in Review

Aviva increased its Nutrien (NTR) stake by 2.8% in Q1 2026, buying an estimated $821K and bringing the position to 422,311 shares worth $31.8M. The position accounts for 0.05% of the portfolio, ranked #305.

Aviva first reported a position in NTR in Q1 2018 and has held it in 33 quarters since. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.

  • Aviva held 422,311 shares of Nutrien worth $31.8M as of Q1 2026.
  • Aviva bought 11,516 Nutrien shares in Q1 2026, an estimated $821K.
  • Nutrien made up 0.05% of Aviva's portfolio in Q1 2026, its #305 holding.
  • Aviva first reported a position in Nutrien in Q1 2018 and has held it in 33 quarters since.
  • 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.

Based on Aviva's 13F filing for Q1 2026, filed 14 May 2026.